p21(WAF1/CIP1) RNA expression in highly HIV-1 exposed, uninfected individuals
- PMID: 25746435
- PMCID: PMC4352077
- DOI: 10.1371/journal.pone.0119218
p21(WAF1/CIP1) RNA expression in highly HIV-1 exposed, uninfected individuals
Abstract
Some individuals remain HIV-1 antibody and PCR negative after repeated exposures to the virus, and are referred to as HIV-exposed seronegatives (HESN). However, the causes of resistance to HIV-1 infection in cases other than those with a homozygous CCR5Δ32 deletion are unclear. We hypothesized that human p21WAF1/CIP1 (a cyclin-dependent kinase inhibitor) could play a role in resistance to HIV-1 infection in HESN, as p21 expression has been associated with suppression of HIV-1 in elite controllers and reported to block HIV-1 integration in cell culture. We measured p21 RNA expression in PBMC from 40 HESN and 40 low exposure HIV-1 seroconverters (LESC) prior to their infection using a real-time PCR assay. Comparing the 20 HESN with the highest exposure risk (median = 111 partners/2.5 years prior to the 20 LESC with the lowest exposure risk (median = 1 partner/2.5 years prior), p21 expression trended higher in HESN in only one of two experiments (P = 0.11 vs. P = 0.80). Additionally, comparison of p21 expression in the top 40 HESN (median = 73 partners/year) and lowest 40 LESC (median = 2 partners/year) showed no difference between the groups (P = 0.84). There was a weak linear trend between risk of infection after exposure and increasing p21 gene expression (R2 = 0.02, P = 0.12), but again only in one experiment. Hence, if p21 expression contributes to the resistance to viral infection in HESN, it likely plays a minor role evident only in those with extremely high levels of exposure to HIV-1.
Conflict of interest statement
Figures
Similar articles
-
Mx2 expression is associated with reduced susceptibility to HIV infection in highly exposed HIV seronegative Kenyan sex workers.AIDS. 2015 Jan 2;29(1):35-41. doi: 10.1097/QAD.0000000000000490. AIDS. 2015. PMID: 25562491
-
HIV-1-specific enzyme-linked immunosorbent spot assay responses in HIV-1-exposed uninfected partners in discordant relationships compared to those in low-risk controls.Clin Vaccine Immunol. 2012 Nov;19(11):1798-805. doi: 10.1128/CVI.00179-12. Epub 2012 Sep 12. Clin Vaccine Immunol. 2012. PMID: 22971780 Free PMC article.
-
Identification of a Specific miRNA Profile in HIV-Exposed Seronegative Individuals.J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):11-9. doi: 10.1097/QAI.0000000000001070. J Acquir Immune Defic Syndr. 2016. PMID: 27171739
-
Genetic and epigenetic regulation of natural resistance to HIV-1 infection: new approaches to unveil the HESN secret.Expert Rev Clin Immunol. 2020 Apr;16(4):429-445. doi: 10.1080/1744666X.2020.1732820. Epub 2020 Mar 5. Expert Rev Clin Immunol. 2020. PMID: 32085689 Review.
-
p21Waf1/Cip1: its paradoxical effect in the regulation of breast cancer.Breast Cancer. 2019 Mar;26(2):131-137. doi: 10.1007/s12282-018-0913-1. Epub 2018 Sep 25. Breast Cancer. 2019. PMID: 30255294 Review.
Cited by
-
Role of Divalent Cations in HIV-1 Replication and Pathogenicity.Viruses. 2020 Apr 21;12(4):471. doi: 10.3390/v12040471. Viruses. 2020. PMID: 32326317 Free PMC article. Review.
-
Sexual role and HIV-1 set point viral load among men who have sex with men.Epidemics. 2019 Mar;26:68-76. doi: 10.1016/j.epidem.2018.08.006. Epub 2018 Aug 30. Epidemics. 2019. PMID: 30193771 Free PMC article.
References
-
- Kaslow RA, Dorak T, Tang JJ (2005) Influence of host genetic variation on susceptibility to HIV type 1 infection. J Infect Dis 191 Suppl 1: S68–77. - PubMed
-
- Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, et al. (1996) Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 273: 1856–1862. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AI035042/AI/NIAID NIH HHS/United States
- U01-AI35040/AI/NIAID NIH HHS/United States
- U01-AI35042/AI/NIAID NIH HHS/United States
- U01 AI035041/AI/NIAID NIH HHS/United States
- P01 AI057005/AI/NIAID NIH HHS/United States
- U01-AI35039/AI/NIAID NIH HHS/United States
- U01 AI035040/AI/NIAID NIH HHS/United States
- U01 AI035039/AI/NIAID NIH HHS/United States
- UM1-AI35043/AI/NIAID NIH HHS/United States
- P30 MH058107/MH/NIMH NIH HHS/United States
- UM1 AI035043/AI/NIAID NIH HHS/United States
- U01-AI35041/AI/NIAID NIH HHS/United States
- R37-047734/PHS HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
